A retrospective study assessing safety and efficacy of Denosumab with Plain Vitamin D or with Analog of Vitamin D Alfacalcidol in Postmenopausal Osteoporosis patients
Latest Information Update: 21 Jun 2019
At a glance
- Drugs Alfacalcidol (Primary) ; Colecalciferol (Primary) ; Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 21 Jun 2019 New trial record
- 15 Jun 2019 Results assessing effectiveness and safety of DMAb in combination with 1aD3 and DMAb in combination with D3 in postmenopausal osteoporosis patients, presented at the 20th Annual Congress of the European League Against Rheumatism.